Theratechnologies Announces Board Elections and Strategic Approvals at Annual Meeting

The latest update is out from Theratechnologies ( (TSE:TH) ).

Theratechnologies held its annual meeting of shareholders, where all proposed candidates were elected to the Board of Directors, KPMG LLP was appointed as the auditor, and an omnibus long-term incentive plan was approved. These decisions are expected to support the company’s strategic goals and enhance its operational framework, potentially impacting its market position and stakeholder interests.

The most recent analyst rating on (TSE:TH) stock is a Buy with a C$3.80 price target. To see the full list of analyst forecasts on Theratechnologies stock, see the TSE:TH Stock Forecast page.

Spark’s Take on TSE:TH Stock

According to Spark, TipRanks’ AI Analyst, TSE:TH is a Neutral.

Theratechnologies faces significant challenges with profitability and high financial leverage, which weigh heavily on the stock’s attractiveness. Despite strong technical momentum and positive corporate developments, the financial instability and valuation concerns lower the overall score.

To see Spark’s full report on TSE:TH stock, click here.

More about Theratechnologies

Theratechnologies is a commercial-stage biopharmaceutical company focused on the commercialization of innovative therapies that aim to redefine standards of care.

Average Trading Volume: 130,084

Technical Sentiment Signal: Buy

Current Market Cap: C$162.8M

Find detailed analytics on TH stock on TipRanks’ Stock Analysis page.